RJ
Rhodes Jennifer J
Autre
OtherF
€200,431
▼ Sales (19 ops.)
Insider track record
OtherAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Rhodes Jennifer J, Autre. Officer active across 2 companies, notably Angion Biomedica Corp.. Cumulatively, 20 filings have been published. Split: 0 buy · 19 sells. Total volume traded: €200k. Activity tracked since 14 May 2021. The latest transaction was disclosed on 9 February 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations20 total
12,944 shares0Common StockSEC:0001568249-26-000002:0
6,950 shares@ US$23.38100.0% of flowCommon StockSEC:0001568249-26-000002:1
451 shares@ US$2.41711.5% of flowCommon StockSEC:0001601485-21-000083
451 shares@ US$2.41711.5% of flowCommon StockSEC:0001601485-21-000083:0
433 shares@ US$4.402.6% of flowCommon StockSEC:0001601485-21-000072:0
433 shares@ US$4.402.6% of flowCommon StockSEC:0001601485-21-000072
430 shares@ US$8.655.1% of flowCommon StockSEC:0001601485-21-000060:0
430 shares@ US$8.655.1% of flowCommon StockSEC:0001601485-21-000060
430 shares@ US$10.646.1% of flowCommon StockSEC:0001601485-21-000056:0
430 shares@ US$10.646.1% of flowCommon StockSEC:0001601485-21-000056
445 shares@ US$10.686.4% of flowCommon StockSEC:0001601485-21-000050:0
445 shares@ US$10.686.4% of flowCommon StockSEC:0001601485-21-000050
432 shares@ US$10.946.4% of flowCommon StockSEC:0001601485-21-000040
432 shares@ US$10.946.4% of flowCommon StockSEC:0001601485-21-000040:0
431 shares@ US$11.016.4% of flowCommon StockSEC:0001601485-21-000033
431 shares@ US$11.016.4% of flowCommon StockSEC:0001601485-21-000033:0
427 shares@ US$13.277.4% of flowCommon StockSEC:0001601485-21-000027
427 shares@ US$13.277.4% of flowCommon StockSEC:0001601485-21-000027:0
440 shares@ US$13.928.0% of flowCommon StockSEC:0001601485-21-000023:0
440 shares@ US$13.928.0% of flowCommon StockSEC:0001601485-21-000023
About Rhodes Jennifer J
Jennifer J Rhodes is associated with Angion Biomedica Corp.